Morgan Stanley raised the firm’s price target on BrightSpring Health (BTSG) to $62 from $48 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health price target raised to $61 from $52 at Mizuho
- BrightSpring Health price target raised to $60 from $50 at Deutsche Bank
- BrightSpring Health price target raised to $60 from $52 at BMO Capital
- BrightSpring Health price target raised to $65 from $60 at TD Cowen
- BrightSpring Health price target raised to $64 from $53 at Stephens